The generic name for Belsomra is suvorexant [1].
When is Suvorexant expected to be available generically?
Suvorexant, marketed as Belsomra, is protected by several patents. The earliest patent expiration relevant to its market exclusivity is anticipated in late 2027 [2]. However, the exact date of generic availability can be influenced by various factors, including patent litigation and the outcome of any challenges [2].
Can generic Belsomra enter the market before patent expiration?
Generic entry before a patent's expiration date is typically only possible if the patent is successfully challenged in court or if a regulatory pathway, such as an Abbreviated New Drug Application (ANDA), is approved based on specific legal provisions [2]. Litigation surrounding drug patents is common and can delay or accelerate generic availability [2].
What is the mechanism of action for Suvorexant?
Suvorexant works by blocking the activity of orexin receptors in the brain [1]. Orexins are neuropeptides that play a role in wakefulness. By inhibiting orexin signaling, suvorexant promotes sleep by reducing the brain's arousal system [1].
What are the approved uses for Suvorexant?
Suvorexant is approved for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance [1].
What are common side effects associated with Suvorexant?
Common side effects of suvorexant include drowsiness, headache, and dizziness [1]. Patients are advised to avoid driving or engaging in other activities requiring full alertness until they know how suvorexant affects them [1].
Who manufactures Belsomra (Suvorexant)?
Belsomra is manufactured by Merck & Co., Inc. [3].
What is the typical pricing for Belsomra?
Pricing for prescription medications can vary significantly based on factors such as insurance coverage, pharmacy, and dosage. As of the information available, Belsomra is a brand-name drug, and its cost reflects that. Generic versions, when available, are generally less expensive [3].
How does Suvorexant compare to other insomnia medications?
Suvorexant is a dual orexin receptor antagonist, a different class of medication compared to traditional hypnotics like benzodiazepines or non-benzodiazepine hypnotics (e.g., zolpidem). These other classes work by enhancing GABAergic inhibition, which is a calming effect on the brain [1]. Suvorexant's mechanism targets the wakefulness system directly [1].
What are the risks associated with Suvorexant use?
In addition to common side effects, potential risks include sleep paralysis, hallucinations, and suicidal thoughts [1]. It is important for patients to discuss their medical history and any concerns with their healthcare provider before starting suvorexant [1].
Where can I find more information on drug patents and exclusivity?
Information on drug patents, exclusivity periods, and potential generic entry can be found on specialized resources like DrugPatentWatch.com [2].